Drug Trial Radar · NCT07525947
A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
Last checked: Nov 19, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
May 1, 2026
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Jade Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.
Conditions
- Healthy Volunteers (HV)
Interventions
JADE101Drug
JADE101 is supplied as sterile solution to be administered by SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability of single dose of JADE101 in healthy Japanese and Chinese participantsTime frame: Day 1 through 48 weeks
- CmaxTime frame: Day 1 through 48 weeks
- TmaxTime frame: Day 1 through 48 weeks
- AUClastTime frame: Day 1 through 48 weeks
- T1/2Time frame: Day 1 through 48 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Parexel Early Phase Clinical Unit (EPCU)
Glendale, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.